Carcinogenesis, Vol. 23, No. 10, 1561-1568,
October 2002
© 2002 Oxford University Press
ACCELERATED PAPER |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene
1 Chemical Carcinogenesis Section, Laboratory of Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892, USA,
2 Advanced Technology Center, Center for Cancer Research, National Cancer Institute, NIH, Gaithersburg, MD 20887, USA and
3 The Institute of Genomic Research, Rockville, MD 20852, USA
cDNA microarray analysis was used to examine gene expression profiles in normal female SpragueDawley rat mammary gland and in carcinomas induced by the cooked meat-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and the potent experimental carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). Nine tubulopapillary carcinomas (five from PhIP-treated rats and four from DMBA-treated rats) and normal mammary gland from virgin, pregnant and lactating rats were examined on a rat 6.9k cDNA microarray. Although histologically identical, PhIP- and DMBA-induced carcinomas could be distinguished by hierarchical clustering and multi-dimensional scaling analyses of cDNA expression. In addition, the expression of 21 clones was statistically different between PhIP- and DMBA-induced carcinomas (F-test, P < 0.05). The data indicate that distinct chemical carcinogens induce unique gene expression patterns in mammary gland carcinomas. The specific chemical carcinogen-associated cDNA array profiles found in carcinomas may ultimately be applicable to better understanding cancer etiology. PhIP- and DMBA-induced carcinomas also shared similarities in cDNA expression profiles. By comparing the expression in carcinomas (PhIP plus DMBA induced) with normal rat mammary gland (at any stage of differentiation), 172 clones were found to be differentially expressed. Genes showing increased expression in carcinomas by cDNA microarray analysis (and further validated by immunohistochemistry and western blot analysis) include cyclin D1, PDGF-A chain, retinol binding protein 1, prohibitin and the transcription factor STAT5A. The similarities in gene expression between PhIP- and DMBA-induced carcinomas raise the possibility that several molecular pathways for rat mammary gland transformation are maintained irrespective of the carcinogenic initiating agent.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Quackenbush Extracting biology from high-dimensional biological data J. Exp. Biol., May 1, 2007; 210(9): 1507 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanco-Aparicio, L. Perez-Gallego, B. Pequeno, J. F.M. Leal, O. Renner, and A. Carnero Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer Carcinogenesis, March 1, 2007; 28(3): 584 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Peng, R. Mehta, S. Wang, S. Chellappan, and R. G. Mehta Prohibitin is a novel target gene of vitamin d involved in its antiproliferative action in breast cancer cells. Cancer Res., July 15, 2006; 66(14): 7361 - 7369. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shan, M. Yu, and E. G. Snyderwine Global Gene Expression Profiling of Chemically Induced Rat Mammary Gland Carcinomas and Adenomas Toxicol Pathol, December 1, 2005; 33(7): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Currier, S. E. Solomon, E. G. Demicco, D. L. F. Chang, M. Farago, H. Ying, I. Dominguez, G. E. Sonenshein, R. D. Cardiff, Z.-X. J. Xiao, et al. Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors Toxicol Pathol, October 1, 2005; 33(6): 726 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. Zwart, E. N. Speksnijder, R. B. Beems, K. P. Olive, D. A. Tuveson, J. Jonkers, M. M. Schaap, J. van den Berg, T. Jacks, et al. Mice Expressing a Mammary Gland-Specific R270H Mutation in the p53 Tumor Suppressor Gene Mimic Human Breast Cancer Development Cancer Res., September 15, 2005; 65(18): 8166 - 8173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Chan, X. Lu, F. M. Merchant, J.D. Iglehart, and P. L. Miron Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer Carcinogenesis, August 1, 2005; 26(8): 1343 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Linder, J. Lundin, J. Isola, M. Lundin, K. O. Raivio, and H. Joensuu Down-Regulated Xanthine Oxidoreductase Is a Feature of Aggressive Breast Cancer Clin. Cancer Res., June 15, 2005; 11(12): 4372 - 4381. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, April 1, 2005; 26(4): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shan, M. Yu, and E. G. Snyderwine Gene expression profiling of chemically induced rat mammary gland cancer Carcinogenesis, February 1, 2005; 26(2): 503 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujiwara, M. Ochiai, T. Ohta, M. Ohki, H. Aburatani, M. Nagao, T. Sugimura, and H. Nakagama Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, August 1, 2004; 25(8): 1495 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shan, M. Yu, C. Qiu, and E. G. Snyderwine Id4 Regulates Mammary Epithelial Cell Growth and Differentiation and Is Overexpressed in Rat Mammary Gland Carcinomas Am. J. Pathol., December 1, 2003; 163(6): 2495 - 2502. [Abstract] [Full Text] |
||||
![]() |
C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine Deregulation of the Cyclin D1/Cdk4 Retinoblastoma Pathway in Rat Mammary Gland Carcinomas Induced by the Food-derived Carcinogen 2-Amino-1- methyl-6-phenylimidazo[4,5-b]pyridine Cancer Res., September 15, 2003; 63(18): 5674 - 5678. [Abstract] [Full Text] [PDF] |
||||





